Diagnostic Performance Comparison of AFP, PIVKA-II, GALAD Model, and ASAP Model Across Two Chemiluminescence Immunoassay Platforms for Hepatocellular Carcinoma.

J Hepatocell Carcinoma · 2026 · PMC12983155 · PMID 41836603

Europe PMC DOI

hedged sentence

0.0569

closest p · 1.1× alpha

0.0569

boldest claim

The sentences

did not reach statistical significancep = 0.0569so close (0.05 < p ≤ 0.1)

The ASAP_Abbott model (AUC = 0.913) exhibited a slightly higher AUC than the GALAD_Abbott model (AUC = 0.901), though this difference did not reach statistical significance (p = 0.0569).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.